Document is current

Article History

Received: 29 December 2024

Accepted: 10 April 2025

First Online: 23 April 2025

Declarations

:

: This study was approved by the Ethics Committee of the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (22/278–3480) and registered in the Chinese Clinical Trial Registry (ChiCTR2200065519, 8/11/2022). The protocol of this study adheres to CONSORT guidelines. Informed consent was obtained from all the subjects. This study was conducted in accordance with the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations.

: Not applicable.

: The authors declare no competing interests.